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Role of the microcin B17 propeptide in substrate recognitibn: 
solution structure and mutational analysis of McbA,-*, 
Ranabir Sinha Roy’, Soyoun Kim*, James D Baleja* and Christopher T Walsh1 
Background: The peptide antibiotic microcin B17 (MccBI 7) contains oxazole 
and thiazole heterocycles formed by the post-translational modification of four 
cysteine and four serine residues. An amino-terminal propeptide targets the 69 
amino acid precursor of MccBl7 (preproMccB17) to the heterocyclization 
enzyme MccBl7 synthetase. The mode of synthetase recognition has been 
unclear, because there has been limited structural information available on the 
MccB17 propeptide to date. 
Results: The solution structure of the MccB17 propeptide (McbA,-,a), 
determined using nuclear magnetic resonance, reveals that McbA,-,a is an 
amphipathic Q helix. Mutational analysis of 13 propeptide residues showed that 
Phe6 and Leu12 are essential residues for MccB17 synthetase recognition. A 
domain of the propeptide was putatively identified as the region that interacts 
with the synthetase. 
Conclusions: MccB17 synthetase recognizes key hydrophobic residues within 
a helical propeptide, allowing the selective heterocyclization of downstream 
cysteine and serine residues in preproMccB17. The determination of the solution 
structure of the propeptide should facilitate the investigation of other functions of 
the propeptide, including a potential role in antibiotic secretion. 
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Introduction 
Microcin B17 (MccB17) belongs to a group of small 
(~10 kDa) ribosomally encoded antibiotics secreted in the 
stationary phase by several strains of Enterobacteriaceae 
[I]. These antibiotics are typically derived from a precursor 
polypeptide consisting of an amino-terminal leader 
(propeptide) linked to a carboxy-terminal domain that is 
often post-translationally modified [2,3]. For MccB 17, two 
Gly-Cys, two Gly-Ser, a Gly-Ser-Cys and a Gly-CysSer 
sequence in the 69 amino acid precursor polypeptide 
(preproMccB17) encoded by the m&A structural gene [4] 
are converted to two thiazoles, two oxazoles, and the bis- 
heterocyclic 4,2-fused oxazole-thiazoles/thiazole-oxazoles, 
respectively, by the mcbBCD gene products that constitute 
the microcin B17 synthetase complex (Figure 1) [S-B]. The 
amino-terminal leader sequence (McbA& is subse- 
quently cleaved and the mature 43 amino acid heterocyclic 
antibiotic comprising residues 27-69 (MccB17) is secreted 
by an export mechanism using the mcbEF gene products 
[9] that show homology to the ATP-binding cassette (ABC) 
family of transport proteins [lo]. Self-immunity to MccB17 
(a putative inhibitor of DNA gyrase) is conferred to the pro- 
ducer strain by m&2, the seventh gene in the MccB17 
operon [l 1,121, by an as yet undetermined mechanism. 
Consistent with antibiotic export occurring through a ded- 
icated ABC transport apparatus, the McbA,-z, propeptide 
bears little resemblance to typical signal sequences 
involved in set-mediated secretion [13]. Instead, the 
propeptide serves as a prime determinant for the recogni- 
tion and recruitment of preproMccB17 by MccB17 syn- 
thetase [8,14]. In this capacity, the microcin propeptide is 
similar to the y-carboxylation site (y-CRS) propeptides in 
blood coagulation preproteins [15,16] that recruit vitamin 
K-dependent y-glutamyl carboxylase for the post-transla- 
tional carboxylation of 10-12 downstream glutamic acid 
residues [ 171. Amino-terminal propeptides that are 
cleaved when peptide antibiotics are secreted are also 
found in bacteriocins secreted by gram positive bacteria, 
such as the lantibiotics nisin, subtilin and salivaricin A 
[‘2,18]. Although the precise functions of these bacteriocin 
propeptides are unclear, the propeptides might be 
involved in the post-translational modification, stabiliza- 
tion and signal-sequence independent secretion of the 
corresponding prepeptides [Z]. 
Although the MccB17 propeptide is known to be essential 
for substrate recognition by the synthetase, it is also remi- 
niscent of the double-glycine-type leader peptides [19] 
that direct the secretion of non-lantibiotics, such as colicin 
V, by ABC transporters. A knowledge of the three-dimen- 
sional structure of the MccB17 propeptide would there- 
fore provide an insight into other biological funct,ions that 
may be served by this type of prosequence. Here, we 
present the solution structure of the MccB17 propeptide 
(McbA,-z,), and structure-based mutational analysis of this 
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Maturation pathway of microcin El 7. The 69 
amino acid structural gene product (McbA, 
preproMccBl7) is ribosomally synthesized. 
An amino-terminal propeptide (McbA,-,,, 
yellow) targets preproMccB17 for processing 
by the heterotrimeric McbB,C,D synthetase 
complex. Four serine (red) and four cysteine 
(blue) residues in the downstream sequence 
(McbA,,-s,) are post-translationally modified 
to oxazole and thiazole heterocycles 
respectively (proMccB17). Two serine 
residues in this domain (orange boxes) 
remain unprocessed. The propeptide is 
cleaved by an unknown protease and the 
mature 43 amino acid polyheterocyclic 
antibiotic (MccB~ 7) is secreted. 
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sequence to determine residues essential for recognition 
by the heterotrimeric McbB,C,D synthetase. 
Results 
Preliminary structural analysis of the MccB17 propeptide 
Primary sequence analysis [ZO] of preproMccB17 indicated 
residues l-20 have a helical conformation. Consistent with 
this prediction, the circular dichroism (CD) spectrum of a 
synthetic McbA,-,, p ro e p p tide (with free amino and car- 
boxy1 termini, McbA,,,-COOH) at physiological pH 
showed distinctive negative ellipticities (Figure Za, minima 
at 205 nm and 220 nm), characteristic of a helical population 
of conformers [Zl]. Addition of 40% trifluoroethanol (TFE) 
enhanced the helix signature. An extended B-sheet-like 
conformation was rapidly populated at the lower pH values 
required for nuclear magnetic resonance (NMR) experi- 
ments, however, as indicated by transition of the CD spec- 
trum to that with a single minimum at 216 nm, positive 
ellipticity below 205 nm and an isodichroic point at 207 nm 
(Figure Za). Furthermore, the addition of TFE did not 
increase helix content below pH 7. Although poor solubility 
of the synthetic propeptide (<SO0 pM) precluded the com- 
plete two-dimensional NMR analysis of McbA,-a,-COOH, 
a limited inspection of nuclear overhauser effect spec- 
troscopy (NOESY) spectra acquired at pH 5.7 suggested a 
mixture of helix and extended conformations. 
Subsequently, the carboxy-amidated derivative of the 
microcin B17 propeptide (McbA,-,,-CONH,) was synthe- 
sized, with the expectation that masking the negative 
charge at the carboxyl terminus would minimize adverse 
interactions with the helix dipole and better mimic the 
covalent attachment of downstream residues (as in pre- 
proMccB17). Although the CD spectrum of McbAiF2,- 
CONH, in water at pH 5.7 indicated that the peptide was 
largely random coil with a small helical population, the net 
helicity increased significantly upon titration with only 
small amounts of TFE (Figure Zb). The addition of TFE 
caused two conformational effects. The first change was 
characterized by an increase in the absolute value of molar 
ellipticity at ‘222 nm that reached a plateau at -20% TFE. 
The second effect was indicated by a similar increase in 
the absolute molar ellipticity at 208 nm that began at about 
20% TFE and was mostly complete at 30% TFE. Both 
observations were consistent with increased stabilization 
of helical conformers by the addition of TFE. Unlike 
MC&-,,- COOH, no drastic conformational change was 
observed for McbA,V2,-CONH, over the pH range 4.5-7.5, 
although a slight erosion of the TFE-stabilized helix con- 
formation was observed above pH 6.5 (data not shown). 
Determination of the solution structure of McbA,-,6-CONH, 
Guided by the CD analyses, one-dimensional lH spectra 
of the microcin leader peptide McbA,+-CONH, were 
examined in aqueous solution and with increasing concen- 
trations of TFE to find optimal conditions for structure 
analysis. For a 1 mM sample in purely aqueous buffer at 
pH 5.7 and 25”C, proton resonances were spectrally dis- 
persed except for the methyl protons (data not shown). In 
particular, the amide protons did not appear together as a 
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Figure 2 
Preliminary conformational analysis of the 
microcin B17 propeptide. (a) Circular 
dichroism spectra of McbA,.,,-COOH 
acquired at different pH values. An overall 
conformational transition from c1 helix to 
0 sheet is observed at pH ~7.5. (b) Circular 
dichroism spectra of McbA,-,,-CONH, upon 
titration with TFE. Stabilization of a helical 
population of conformers is mostly complete 
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single broad resonance of overlapping peaks near 8.4 ppm, 
but were spread between 7.9 and 8.5 ppm. After recording 
two-dimensional NMR spectra for -48 h, the sample 
formed a gel, however, and spectral quality was greatly 
diminished. In 20% TFE, an NMR spectrum was practi- 
cally unobtainable, presumably because of the extensive 
line-broadening caused by intermediate-rate exchange 
between two or more conformers. Upon addition of TFE 
to 30% or above, however, the NMR spectrum was 
restored, but the resonance lines were slightly more dis- 
perse, especially in the methyl region, indicating a more 
ordered structure than that observed without TFE. 
The improved solubility of McbA,-,,-CONH, in 40% 
TFE (>Z mM) allowed a detailed analysis of the 
peptide’s solution structure. Two-dimensional NMR 
spectra of the peptide were recorded at 25°C in purely 
aqueous solution at pH 4.3 and in 40% TFE buffer at 
pH5.7. The helical structure indicated by the CD 
studies was confirmed by the pattern of NOE cross- 
peaks for the peptide in 40% TFE (Figure 3). In the 
amide-amide proton region of the NOESY spectrum 
strong cross-peaks between sequential residues were 
observed for residues 6-22. Short-range and medium- 
range interactions were defined from the NOESY spec- 
trum using the resonance assignments. Vicinal coupling 
constants between amide and Ccx protons were measured 
from the observed splitting of amide proton cross-peaks 
in a resolution-enhanced NOESY spectrum [Z?]. For 
residues S-19, the coupling constants were small 
(< 6 Hz), suggesting dihedral angles that were consistent 
with a-helix formation. The coupling constant data, 
amide-amide proton NOE interactions, and medium- 
range [Ha(i),HP(i+3)] NOE interactions defined a helical 
segment for the peptide between residues Ala5 and 
Arg21 (Figure 3). The absence of long-range NOE inter- 
actions between protons separated by four or more 
residues in the primary sequence indicated the lack of a 
compact tertiary structure and suggested that the peptide 
adopted an extended structure with the approximately 
central residues in a helical conformation. The helical 
structure was also supported by the observed chemical 
shifts of CCX protons for residues S-20, that were shifted 
upfield by about 0.2 ppm relative to the ‘standard’ chem- 
ical shifts expected for an unstructured peptide [23,24]. 
The deviations from random coil values for Ha chemical 
shifts in 40% TFE mirrored the trends observed for the 
peptide in aqueous solution, but were slightly larger. The 
differences between the two solvent conditions were 
greatest at the immediate boundaries of the helix 
(residues 2-4 and residues 22-24) and near residue 12. 
Significantly, NOE data for the peptide in purely 
aqueous solution also showed sequential HN-HN cross- 
peaks for residues 5, 6 and 1.5-22. Other possible cross- 
peaks were masked by limited spectral dispersion and by 
poor signal-to-noise ratios as a result of limited sample 
solubility. Nevertheless, these results imply that 40% 
TFE stabilizes the structure inherent to the peptide in 
aqueous solution. 
To determine the three-dimensional structure in detail for 
Mcb&j- CONH, in 40% TFE, NOESY cross-peaks were 
converted into a set of distance restraints and calibrated 
using published methods [25,26]. From the coupling con- 
stant data, corresponding torsion angles were measured 
[27]. A set of 251 distance restraints and 23 torsion angles 
were used to generate 2.5 final structures using a combina- 
tion of simulated annealing and distance geometry 
methods. The calculated structures were superimposed 
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Summary of conformational data for the 
microcin 617 propeptide (McbA,-,,-CONH,). 
NOE cross-peaks describing amide-to-amide 
contacts, Ha-amide contacts, HP-amide 
contacts and Ha(i)-HP(i+3) contacts are 
represented by the height of the filled-in bar 
corresponding to NOE intensity. The absence 
of a bar indicates that the NOE was not 
observed. Coupling constants to amide 
protons are indicated with filled circles for 
3J(HN,Ha) <6 Hz, open circles for sJ(HN,Hcz) 
>7 Hz, and shaded circles for 3J(HN,H~) 
between 6 and 7 Hz. The chemical shift index 
(CSI) is shown as positive if the difference 
between the observed Ha chemical shift and 
that for a random coil peptide was greater 
than + 0.1 ppm, and negative if it was less 
than - 0.1 ppm. 
over residues 5-21 because these residues have uniformly 
well defined 4 and w angles (Figure 4a). The pair-wise root 
mean square (rms) deviation for superimposed backbone 
atoms is 0.4 +_ 0.2 A; for all heavy atoms it is 1.0 + 0.3 A. 
PROCHECK analysis [28] showed that the backbone con- 
formations of these residues were in the most favored 
region of the Ramachandran diagram (about SO%), or in the 
additional allowed region (about 20%), indicating a well- 
determined structure. The peptide adopts a helical confor- 
mation from Ala5 to Arg21 and has unstructured ends. 
The propeptide helix is stabilized by two putative salt 
bridges (Lysl-Glu7 and AsplS-Lysl8, Figure 4b) and 
helix dipole neutralization, in part by GluZ and by Arg21. 
Three serine residues (Ser6, Serl3 and Ser20) are aligned 
on one face of the helix forming a polar surface 
(Figure 4b) that could be a possible site of interaction with 
the enzyme complex. In addition, a hydrophobic patch 
was found that comprises the well-ordered sidechains of 
Phe8, LeulZ and, to a lesser extent, Valll. These struc- 
tural features were expected to be relevant for recognition 
by the MccB17 synthetase complex, and the relative 
importance of particular amino acid residues was tested by 
site-directed mutagenesis. 
Site-directed mutagenesis of the microcin 817 propeptide 
Structure-function effects of propeptide mutations would 
have been facilitated if McbAie2, could be tested in tram 
with downstream substrate fragments (eg. McbAZTd6). 
Although this two-peptide strategy employing effector 
and substrate fragments has been successfully used for 
measuring the activity of Vitamin K-dependent y-car- 
boxylase in vitro [29], preliminary experiments had indi- 
cated that it would not work for microcin B17 synthetase 
[8]. Indeed, in synthetase assays in which up to 100 yM 
Mcbi&- COOH or McbA,-2,-CONH, was added in 
tram to downstream fragments (McbAZ7+s, up to 2.5 mM, 
or a-amino-acetylated McbAZTd6, up to 1.2 mM), no het- 
erocycle formation was detected (data not shown). Thus, 
the McbA,-26 p ro e P p tide must be covalently connected 
to the downstream sequence for synthetase-mediated 
heterocycle formation. Furthermore, deletions in the 
polyglycine ([Gly] ,s) linker connecting the propeptide to 
the first bis-heterocyclization site resulted in loss of 
turnover for analogs incorporating less than five glycine 
residues [30]. In the light of these experiments, the 
McbA1-4, fragment incorporating the propeptide and the 
first bis-heterocyclization site (Gly39-Ser40-Cys41, 
Figure 1) was used as a minimal substrate for in vitro pro- 
cessing by the synthetase. 
Site-directed mutagenesis (instead of chemical synthe- 
sis) was used to generate the 13 propeptide analogs 
described here. Individual residues in the MccB17 
propeptide helix were varied to identify sidechains that 
are critical for recognition by the MccB17 synthetase. 
Mutagenesis of the propeptide segment was performed 
within a maltose-binding protein (MBP)-McbA,,, 
fusion protein framework reported earlier [30]. The rela- 
tive efficiencies of 4,2-fused oxazole-thiazole formation 
in substrate analogs incorporating the different mutant 
propeptides were assessed by Western blots probed with 
antibodies raised against mature MccB17 that recognize 
heterocyclic polypeptide products but not preproM- 
ccB17 or fragments of preproMccB17 [6]. These poly- 
clonal anti-MccB17 antibodies also recognize McbA,,, 
analogs containing only a single oxazole or thiazole 
heterocycle at positions 40 or 41 [30]. 
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Solution structure of the microcin 617 propeptide. (a) Stereoview residues are orange. For clarity, the sidechains of residues l-3 and 
overlay of calculated backbone structures for the microcin leader 22-26 have been omitted. (b) Ribbon diagram of the microcin B17 
peptide (McbA,-,,-CONHJ. The backbone atoms for 25 structures propeptide helix highlighting key structural features. Two putative salt 
were superimposed for residues 5-21. The pair-wise rms deviation for 
these ordered residues was 0.4 f 0.2 A. Sidechains were well ordered 
bridges (Lys4-Glu7 and Asp1 5-Lysl6) stabilize the helix. Key 
hydrophobic residues (Phe6 and Leul2) on the nonpolar face are 
for residues 5-20. The sidechains of acidic residues are red, those of 
basic residues are blue, serine residues are green and hydrophobic 
recognized by MccBl7 synthetase. An array of serine residues (Ser6, 
Ser13 and Ser20) span the moderately polar face of the helix. 
Mutagenesis of the polar face of the propeptide helix 
To determine whether the moderately polar face com- 
prising residues Ser6, Ser13 and Ser20 was important for 
interaction with the McbB,C,D synthetase, each serine 
residue was individually replaced by alanine in mutants 
S6A, S13A and SZOA. The MBP-McbA,,, mutants were 
purified by affinity chromatography on an amylose 
column. Western blots for incubation of these substrate 
analogs with affinity-purified calmodulin-binding peptide 
(CBP)-tagged MccB17 synthetase are presented in 
Figure 5, along with the wild-type MBP-McbA,,, (WT) 
results for comparison. No appreciable difference in the 
efficiency of heterocycle-containing product formation 
was observed for any particular mutant protein, indicating 
that the serine residues (and the polar helix face) were 
not essential for synthetase recognition. 
Role of the putative salt bridges in propeptide recognition 
The stabilization of a helices by salt bridges (electrosta- 
tic and hydrogen bond interactions between charged 
residues of opposite polarity), which lock the folded con- 
formation, is well documented [31-331. Two salt bridges 
(Lys4-Glu7 and AsplS-Lysl8) are suggested by the 
Figure 5 
I WT S6A S20A 
I 
S13A 
--- -  
0 30 60 0 30 60 0 30 60 0 30 60 min 
48.3 kDa - 
Product + 
Chemistry 8 Biology 
Protein immunoblots for incubations of MBP-McbA,-,, &VT), and 
mutants S6A, S13A and S20A with CBP-tagged MccB17 synthetase. 
Comparable time-dependent bis-heterocyclic product formation is 
observed in each system. The -67 kDa band in each lane arises from 
nonspecific recognition of a contaminant in the synthetase preparation 
by the polyclonal anti-MccB17 antibodies used in the Western assay. 
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Effects of electrostatic perturbations on heterocyclization of wild-type 
and mutant propeptides. Relative kinetics of processing by MccBl7 
synthetase for MBP-McbA,-,, (WIJ, and the propeptide mutants 
MKLE, KALD and EASK. U, arbitrary units. 
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Relative kinetics of heterocyclization for MBP-McbA,-,, (WT) and 
different propeptide mutants. U, arbitrary units. 
solution structure of the propeptide helix. As Lys4 is 
proximal to Glu2, an electrostatic interaction between 
the sidechains of these residues is also possible. Mutage- 
nesis of these positions was therefore performed to evalu- 
ate the importance of electrostatic interactions in the 
propeptide helix. Each putative salt-bridge pair was 
inverted in the propeptide primary sequence to assess 
the impact of a reversed charge polarity on synthetase 
binding and substrate turnover. Thus, MBP-McbA,,, 
proteins MKLE, EASK and KALD incorporate propep- 
tides with the putative ‘reversed’ salt bridges LysZ-Glu4, 
Glu4-Lys7 and Lysl5-Aspl8, respectively. The relative 
kinetics of processing for these substrate analogs by the 
synthetase are illustrated in Figure 6. Interchanging Lys4 
and Glu2 in mutant MKLE did not appreciably perturb 
the initial rate of turnover relative to WT. In contrast, the 
EASK and KALD mutants had a considerable lag phase 
(5-15 min), and the KALD protein was processed 
approximately ninefold slower than WT. The unusual 
kinetics observed with the EASK and KALD mutants 
may result from an initial weak recognition of the mutant 
propeptides leading to slow formation of the first hetero- 
cycle and positive cooperativity precipitating rapid for- 
mation of the second heterocycle. 
Identification of propeptide residues essential for 
synthetase recognition 
The ArgZl+Asn (RZlQ), Phe8+Ala (F8A), and 
LeulZ+Ala (LlZA) propeptide mutants were investi- 
gated next in a search for individual charged or hydropho- 
bic residues that might serve as key recognition features 
for the MccB17 synthetase. As shown in Figure 7, RZlQ 
was comparable to the wild-type substrate in turnover effi- 
ciency. In contrast, no heterocycle formation was detected 
in Western blots with the F8A and LlZA analogs, thus 
implicating Phe8 and Leul2 as important residues in 
propeptide recognition. To further elucidate the sidechain 
requirements in this region, the PheB+Trp (F8W) mutant 
was evaluated. A prerequisite for aromatic/hydrophobic 
residues at position 8 was confirmed by the turnover of 
F8W, albeit at a rate fourfold slower than that of WT. 
The complete absence of turnover observed with the FSA 
and LlZA substrate analogs could be a result of an altered 
(nonproductive) binding mode of the mutant propeptides, 
or could arise from a lack of synthetase recognition of the 
modified propeptides. To distinguish between these two 
possibilities, the binding competence of one of these 
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Protein immunoblot for assaying the inhibitory capacity of propeptide 
mutant F8A in the turnover of MBP-McbA,-,, by MccBl7 synthetase. 
Less than 10% inhibition in the turnover of substrate (10 FM) is 
observed upon the addition of up to 100 PM F8A. 
proteins (F8A) was evaluated in a competition assay with 
WT. Figure 8 shows the Western blot for a 10 min incuba- 
tion of WT substrate (10 pM MBP-McbA,,,) with syn- 
thetase and increasing concentrations of FSA (O-100 PM). 
No significant inhibition in the turnover of MBP-McbAra 
was detected upon titration with F8A, even when F8A was 
in large excess (<lo% inhibition at 100 FM F8A). These 
data imply a decrease in substrate-binding affinity of at 
least ZOO-fold upon substitution of Phe8 (or by inference, 
LeulZ). Thus, the failure of the F8A mutant as both a sub- 
strate and an inhibitor reflects the inability of MccB17 syn- 
thetase to recognize and bind propeptides lacking 
hydrophobic residues at positions 8 or 12. 
Distortion of helical structure disrupts substrate recognition 
To establish further the relevance of the propeptide helix 
conformation to its biological role of substrate recognition, 
the effect of incorporating a ‘helix breaker’ (proline) was 
examined at three different positions in the helix. Residues 
Phe8, Valll and Va114 were each replaced by proline in 
mutants FSP, VllP and V14P, respectively. The turnover 
kinetics for each protein are shown in Figure 7. Substrate 
analog Vl 1P was processed only slowly, with a considerable 
lag phase. Furthermore, proteins F8P and V14P were com- 
pletely inactive as substrates. As Vail 1/14-+Ala mutations 
in full length McbA do not affect antibiotic efficacy in 
bioassays with MccB17-sensitive strains [34], the disrup- 
tion in substrate turnover for mutants VllP and V14P 
must arise from the conformational consequences of intro- 
ducing proline into the propeptide helix. Similarly, 
although the Phe8+Pro substitution in mutant FSP does 
not drastically alter the hydropathic profile of the propep- 
tide sequence, the resulting helix distortion is sufficient to 
abolish substrate turnover completely. 
Discussion 
Many post-translationally modified polypeptides arise 
from precursors incorporating an amino-terminal leader 
peptide. The leader peptide often contains the determi- 
nants for recognition by the modifying enzyme or enzyme 
complex, and is removed concomitant with formation or 
secretion of the mature product. Propeptide recognition 
elements are observed in blood coagulation proteins such 
as prothrombin and Factor IX, which incorporate y-car- 
boxylase recognition sequences [ 161, and in lantibiotics 
secreted by gram-positive bacteria, in which leader 
sequences direct the carboxy-terminal domains for enzy- 
matic modifications such as dehydration and thioether ring 
formation [35]. Similarly, MccB17, a DNA gyrase inhibitor 
[36] secreted in stationary phase by several strains of 
Eden&a coli and the object of this study, arises from the 
post-translational heterocyclization of a 69 amino acid pre- 
cursor polypeptide (McbA) incorporating a 26 residue 
leader sequence that forms the recognition determinant 
for microcin B17 synthetase [S]. 
The three-dimensional structures of leader peptides have 
typically been studied in the absence of their target 
enzymes [37-391. The enzymes that recognize the leader 
sequences are either membrane bound or contain multiple 
subunits, and have therefore been unavailable in quanti- 
ties sufficient for biophysical characterization in the form 
of complexes. The leader sequences adopt a mostly 
unstructured conformation in aqueous solution (in the 
absence of partner protein), but readily form a-helical seg- 
ments in the presence of TFE. TFE usually does not 
induce helical structure, rather it stabilizes helices in 
regions with an intrinsic a-helical propensity [40,41]. The 
leader sequence of prothrombin [39] and the homologous 
region from Factor IX [37] form an amphipathic helix in 
40% TFE and the amino acid residues important for 
recognition (as determined by mutagenesis) are located on 
a hydrophobic patch on a face of the helix near the amino 
terminus. Similarly, the leader sequence for the precursor 
form of the lantibiotic nisin, although mostly unstructured 
in aqueous solution [38], readily formed an amphipathic 
helix in the presence of TFE. 
In this work, the microcin B17 leader peptide has been 
observed to form an a helix (residues 5-21) that was sta- 
bilized by TFE in aqueous solution. The propeptide is 
separated from the first heterocyclization site (Gly39- 
SerLCO-Cys41) by a polyglycine stretch of 10 residues that 
is unlikely to be structured. The leader sequence and 
the modified portion of the MccB17 substrate thus 
appear to be two independent folding units. A similar 
phenomenon has been observed for pronisin; the confor- 
mation of the nisin portion is unchanged by the presence 
of the leader sequence [38]. Furthermore, the MccB17 
propeptide fragment (McbA,& inhibits synthetase- 
mediated bis-heterocyclization of McbAi,, with an IC,, 
value comparable to the K, of substrate [S]. Thus, the 
recognition and modification elements of preMccB17 
precursor appear to be separable functions, although the 
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Mutagenesis results mapped onto the solvent accessible surface of 
the propeptide helix. Diametrically opposite views are shown. 
Residues that can be substituted without adversely affecting 
synthetase-mediated heterocyclization or antibiotic efficacy are yellow. 
Also included in this category are the serine residues highlighted in 
blue on the right (Ser6, Ser13, Ser20). Reversals of putative salt 
bridges that decrease turnover or bioactivity are highlighted in orange. 
Hydrophobic residues essential for synthetase recognition are red 
(Phe6 and Leul2). A probable domain of propeptide interaction with 
the synthetase complex emerges in the view on the left (orange/red). 
Residues not included in this analysis are colored white. 
polyglycine linker is essential to achieve a correct regis- 
ter between the a-helical propeptide and cyclizable 
serine and cysteine residues [30]. 
Figure 10 
The structure-function data reported here for 13 propep- 
tide mutants in the context of McbA,,, substrate analogs 
can be interpreted on the basis of the solution structure 
obtained for McbA,+ Perturbations in synthetase-medi- 
ated turnover of individual MBP-McbA,, propeptide 
mutants were mapped onto the three-dimensional structure 
of the propeptide fragment to produce the model depicted 
in Figure 9. Bioactivity data [34] for antibiotic efficacy of a 
complementary set of mutations in the leader sequence of 
McbA were also included in the analysis (Figure 10). Those 
data were obtained by comparing zones of growth inhibi- 
tion on lawns of MccB17-sensitive indicator cells exposed 
to cell extracts containing the mature McbA mutants, and 
would score mutations that affected not only post-transla- 
tional heterocyclization, but also subsequent proteolytic 
cleavage of the propeptide and secretion of mature 
MccB17. As shown in Figure 9, mutations that adversely 
affect substrate processing are clustered on a single face of 
the propeptide helix, spanning residues Lys4, Glu7, Phe8, 
LeulZ, Asp15 and Lysl8. This face probably represents the 
domain that interacts with the synthetase complex during 
the initial recognition of the 69 amino acid McbA substrate 
by the McbB,C,D synthetase complex. 
The strategy of recruiting hydrophobic sidechains spaced 
four residues apart in the leader (Phe8, Leul2) for recogni- 
tion by modifying enzymes may be a general one. The pre- 
cursor propeptide for trifolitoxin [42], a rhizobial peptide 
that contains a thiazoline heterocycle derived from the post- 
translational modification of Cys [43], shows limited homol- 
ogy to Mcb&,, but has an equivalent pattern of 
hydrophobic residues in the putative helical prosequence 
(Ile16, Phe20 and Leu24). These residues may therefore 
provide most of the recognition determinants for TfxB, -D, 
and -F, the cognate enzymes for post-translational modifica- 
tion [42]. Although the serine residues in the microcin 
leader are not important for substrate recognition by the 
heterocyclizing synthetase, the moderately polar face 
spanned by these residues might constitute a second recog- 
nition surface for interaction with the cell membrane, and 
target preproMccB17 for secretion by the membrane-bound 
A IOII AA 1 % Efficacy 
(relative to MccB17) 
% Turnover after 1 h 
(relative to WT) 
Summary of structure-activity relationships for 
the MccBl7 propeptide. Bioassay data [34] 
are indicated in black Mutagenesis results from 
this study are presented in blue. Pair-wise 
mutations are connected by a horizontal line. 
The bioassay data for Met1 and Glu2 mutants 
were excluded in the map shown in Figure 9, 
because antibiotic efficacy perturbations 
resulting from substitutions at these positions 
were attributed to decreases in translational 
efficiency of the mutant mcbA structural gene. 
Al= AP Chemistry 8 Biology 
Research Paper Analysis of the kc61 7 propeptide Sinha Roy et a/. 225 
Figure 11 
Proposed model for the substrate-synthetase 
interaction in the microcin 617 system. The 
amino-terminal propeptide sequence (yellow) 
is initially recognized by a specific domain 
(orange) in the MccBl7 synthetase complex. 
Residues Phe8 and Leul2 (green) play key 
roles in this recognition event. The polyglycine 
linker acts as a spacer and sets the register to 
allow heterocyclization of specific downstream 
serine (red) and cysteine (blue) residues at a 
spatially distinct active site (white) in the 
synthetase. The shortest functional linker in 
this regard comprises five glycine residues 
[G,] [301, allowing an estimate of the 
separation between the propeptide recognition 
domain and the heterocyclization active site(s). 
The moderately polar propeptide face includes 
an array of serine residues that might interact 
with the inner membrane and target the 
processed antibiotic for secretion by the 
dedicated MccBl7 transporter (McbE,F), 
concomitant with cleavage of the propeptide 
leader sequence. 
16-30A 
GG G SCGGQGG 
G G G” ‘11-L- Gc~G..- 
GGG 
Synthetase 
m Microcin B17 synthetase complex 
m Propeptide recognition domain 
0 Active site(s) 
Inner membrane 
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dedicated transporter (McbE,F). A similar array of serine 
residues (Ser260, Ser271 and Ser282) has been observed in 
the amphipathic helical domain of the amphitropic regula- 
tory enzyme CTP:phosphocholine cytidyltransferase that 
interacts with the lipid bilayer [44]. As in this system, Ser6, 
Ser13 and Ser20 in the MccB17 propeptide might serve to 
limit the hydrophobicity of the membrane interaction face 
and modulate the selectivity of lipid binding. 
The polyheterocyclization achieved by interaction of 
McbA as substrate with McbB,C,D as catalysts is remark- 
able both in terms of the chemical reactions and position- 
ing of the residues that determines which serine and 
cysteine residues get cyclized. Together with mutagenesis 
results at the Gly39-Ser4O-Cys41 bis-heterocyclization site 
of McbA [30], the studies presented here on the MccB17 
propeptide suggest the two-site interaction model pre- 
sented in Figure 11 for protein-protein recognition in the 
microcin B 17 system. 
Significance 
The DNA-gyrase-targeting activity of the Escherichia coli 
peptide antibiotic microcin B17 (MccB17) depends on 
the unusual post-translational modification of six glycine, 
four serine and four cysteine residues (spanning residues 
39-67 of the McbA structural gene product) to four 
oxazole and four thiazole heterocycles. The heterocy- 
clization process completely depends on upstream 
residues (McbA& that serve as the high affinity recog- 
nition element for the processing McbB,C,D enzyme 
complex. The solution structure of the propeptide 
Mcb-$-as CONH, reveals an amphipathic a helix span- 
ning residues S-21. This analysis, using nuclear magnetic 
resonance, facilitated site-directed mutagenesis of pro- 
peptide residues within a competent substrate fragment 
(McbA1+). The structural and mutagenesis data were 
subsequently combined to map the initial interaction 
surface of the McbA substrate with the McbB,C,D syn- 
thetase complex. The hydrophobic patch, containing 
Phe8 and Leu12, in the MccB17 propeptide is a key 
binding determinant. This work sets the stage for evalu- 
ating the effects of McbA propeptide mutations on inter- 
actions with the transport (McbE,F) and immunity 
(McbG) proteins of the MccB17 operon, which might 
affect antibiotic secretion and efficacy. 
Materials and methods 
CBP-tagged microcin B17 synthetase incorporating the McbB subunit 
affinity-labeled with calmodulin-binding peptide 145,461 was overex- 
pressed and purified as reported earlier 1301. Polyclonal rabbit anti- 
MccBl7 antibodies were generated by East Acres Biologicals. 
Horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (H+L) 
polyclonal antibody was purchased from Pierce. Plasmid pMSS10 encod- 
ing the MBP-McbA,-,, fusion protein under control of the T7 promoter, 
and plasmid plADL14 encoding MBP-VanX fusion protein have been 
described elsewhere [30,471. Oligonucleotide primers were obtained 
from Integrated DNA Technologies, Gene Link, or Biosource International. 
Peptide synthesis 
Synthetic polypeptides McbA,-,,-COOH and McbA,-,,-CONH, were 
synthesized on an automated peptide synthesizer at the Howard 
Hughes Biopolymer Facility, Harvard Medical School using solid phase 
Fmoc-based peptide synthesis [481. Each polypeptide was purified by 
C,, reversed phase high performance liquid chromatography (HPLC) 
and its identity was confirmed using matrix-assisted laser desorption 
ionization (MALDI) mass spectrometry. 
Circular dichroism spectroscopy 
CD spectra were recorded with an Aviv Model 62DS CD spectropho- 
tometer. Spectra were baseline corrected and noise-reduced using 
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Aviv system software. The ellipticity (8,,,) of polypeptide solutions 
(20-50 PM) in 10 mM phosphate or acetate buffer was measured at 
25°C over the range 190-280 nm using four scans and an averaging 
time of 1 s in a 0.1 cm cuvette. The CD data are reported as mean 
residue ellipticity (181, in deg.cm2.dmol-1). 
NMR spectroscopy and structure calculation 
Lyophilized peptide (2 or 4 mM) was solubilized in a buffer containing 
100 mM NaCl, 10 mM NazHPO,, and 10 mM NaHzPO,, pH 4.3 or in a 
buffer containing 40% TFE, 100 mM NaCI, 10 mM N%HPO,, and 
10 mM NaH,PC,, pH’ 5.7. Samples also contained 10% D,O for the 
deuterium lock signal. For 4 mM samples in D,O, the peptide was 
lyophilized and then redissolved in 99.96% D,O and 40% TFE, pH 5.7. 
Spectra were collected at 15“C and 25°C on a Bruker AMX-500 spec- 
trometer with a proton frequency of 500.14 MHz. The carrier frequency 
was set on the water resonance, which was suppressed using presatura- 
tion. Two-dimensional NOESY, total correlation spectroscopy (TOCSY), 
and double quantum filtered correlation spectroscopy (DQF-COSY) 
spectra (491 were collected in H,O, and a NOESY spectrum was 
obtained in D,O to uncover proton signals buried underneath the water 
resonance. NOESY spectra were obtained at two different temperatures 
to separate overlapping resonances or to shift resonances bleached out 
by saturation of the water resonance under one set of conditions but not 
the other. NOESY spectra were acquired with mixing times of 250 ms for 
the sample at 25’C and 400 ms at 15°C. A total of 4096 real data points 
was acquired in t, with 512 time-proportional phase increments in t,, a 
spectral width of 6024 Hz, 144 summed scans, and a relaxation delay of 
1.2 s between scans. Spectra were multiplied with sine-bell window 
functions shifted by 45’ in t, (applied over 1024 points) and 60’ in t, 
(applied over 512 points) and zero filled to a 2048 x 1024 (real) matrix 
using Bruker NMR processing software. NOESY cross-peak intensities 
were converted into distance restraints and calibrated against internal 
standards involving amide proton-to-Ha distances 125,261. A TOCSY 
spectrum was recorded and processed using parameters identical to the 
NOESY experiment, except with a mixing time of 46 ms, 96 scans, and 
using an MLEV-17 mixing sequence [49]. A DQF-COSY spectrum was 
collected with 2048 real t, points using a spectral width of 6024 Hz, 
788 t, TPPI increments, and a relaxation delay of 1.3 s between scans. 
Spectra were apodized with sine bells shifted by 30” in t, and by 45” in 
t, and zero-filled to a 2048 x 1024 (real) matrix. 
Protons were assigned to their resonance positions following standard 
homonuclear methods [271. Briefly, intraresidue connectivities were 
established via TOCSY and DQF-COSY experiments followed by a 
search for sequential (HN(i),HN(i+l)), (Ho(i),HN(i+l)), and 
(HP(i+l),HN(i+l)) cross-peaks in the NOESY spectrum. Starting 
points for assignment were identification of the amino acid spin 
systems for the single phenylalanine residue Phe8, the single aspartate 
residue Asp1 5, and the single arginine residue Arg21. 
NOESY cross-peak intensities were converted into distances and cali- 
brated using published methods [25,26]. Comparison of NOESY 
spectra collected at two mixing times was used to control for spin diffu- 
sion effects. Non-stereospecifically assigned atoms were treated as 
pseudoatoms and given correction distances [27]. The vicinal coupling 
constants, 3J(HN,Hrx), were measured from the splitting of cross-peaks 
in the HN dimension in a NOESY spectrum that was resolution- 
enhanced during processing using a squared sine-bell window function 
shifted by 30’ applied over 2048 (real) points in t, [221. Only residues 
with 3J(HN,Ha) < 8 Hz were used for structure determination (15 in 
total). For some residues, $ angle constraints were limited to the nega- 
tive range by referring to both the size of the coupling constants and 
intensity of NOE cross-peaks for intraresidue dNfi,i), and sequential 
dN(i,i+l) and dNNfi,i+l) connectivities [50]. xl torsion angles and 
P-methylene proton stereospecific assignments were determined from a 
measurement of 3J(Ha,Hf3), and a comparison of the HP-HN and Ha-HP 
cross-peak intensities in the NOESY spectra for each stereospecific 8 
proton of AMX residues. 3J(Ha,H8) (11 in total) were measured from the 
splitting in the Ho dimension of cross-peaks from a NOESY spectrum 
collected in D,O solution. x, Torsion angles for valine residues were 
obtained for a measurement of sJ(Ha,HP) and an analysis of the Ha-HP 
NOE cross-peak shapes [511. 
Structure determination used a set of 251 distance restraints and 26 
torsion angles that were entered into the DGII program of Insight11 
(Biosym Technologies, San Diego, CA). A combination of distance 
geometry and simulated annealing methods generated 30 structures 
using previously published methods [52], of which 29 converged, and 
25 structures were randomly chosen and used for further analysis. They 
were superimposed using the backbone atoms over well defined 0 and 
w angles [251. The average rms deviation values and PROCHECK 
analysis 1281 reflected the quality of the structures determined. 
Site-directed mutagenesis of MBP-McbA,-,, 
The 1371 base pair Xbal-Xhol fragment from pMSSl0 was subcloned 
into the 5192 base pair vector backbone obtained from XballXhol 
digestion of plasmid plADLl4 to generate plasmid pMSS46 (microcin 
synthetase substrate) using recombinant DNA techniques described 
elsewhere [53]. Plasmid pMSS46 is identical to plasmid pMSSl0 
except for the presence of a Smal site in the former. 
Propeptide mutants S6A, S13A, and S2OA were generated by Unique 
Site Elimination (USE) mutagenesis (541 of plasmid pMSSl0 as 
described earlier 1301, with the selection primer 5’-CCCATACAATCGGT- 
AGATTGTCGCAGS’ (for elimination of the C/al site), and the following 
mutagenic primers: S6A, 5’-GAATTAAAAGCGGCTGAATTTGGTGT-3’; 
S13A, 5’-GGTGTAGTTTTGGCCGT-TGATGCTCTT-3’; S20A, B’-GCT- 
ClTA-AATTAGCACGCCAGTCTC-3’. Propeptide mutant V14P was 
constructed by USE mutagenesis of pMSS46 with the mutagenic primer 
5’-GGTGTAGTTFTGTC-CCCTGATGCTCTTAAAlTATCACGG3’. 
Propeptide mutants MKLE, EASK, F8A, F8W, F8P, Vl 1 P and L12A 
were generated by PCR mutagenesis of plasmid pMSSl0 (MKLE, 
F8A, F8W, Vl 1 P) or pMSS46 (EASK, F8P, L12A) using the BarnHI 
and Dralll sites, as described elsewhere [301. The reverse primer was 
5’-CGTCTATCAGGGCGATGGCCCACTACG-3’ and the forward 
primers were: MKLE, 5’-ACGAGGATCCATGAAAAAATTAGAAGCGAGTG- 
AAl-l-fGG-3’; EASK, 5’-ACGAGGATCCATGGAAT-TAGAAGCGAGT- 
AAAllTGGTGTAG-3’; F8A, 5’-ACGAGGATCCATGGAATTAAAAG- 
CGAGTGAAGCGGGTGTAGlllTGTCCG-3’; F8W, 5’-ACGAGGAT- 
CCATGGAAT-TAAAAGCGAGTGAATGGGGTGTAGlTlTGTCCG-3’; 
F8P, 5’-ACGAGGATCCATGGAATGCGAGTGAACCGGGT- 
GTAGB’; Vl 1 P, B’-ACGAGGATCCATGGAAT-TAAAAGCGAGT- 
GAATTTGGTGTACCG-T-TGTCCGTTG-3’; L12A, 5’-ACGAGGATC- 
CATGGAAT-TAAAAGCGAGTGAATTTG-GTGTAGTTGCGTCCGTT- 
GATGC-3’. Mutant propeptides KALD and R21 Cl were constructed by 
PCR mutagenesis of pMSSl0 using the Bsiwl and Avrfl sites, the 
forward primer 5’-GGATGCCGTACGTTACAACGGCAAGCTG-3’, and 
the reverse primers: KALD, 5’~AACACCTAGGGGAGACTGGCGT- 
GATAAATCAAGAGCTTTAACGGA-CAAAAC-3’; R21 Q, B’CCAAC- 
ACCTAGGGGAGACTGCTGTGATAATTTAAGAG-CATCAACG-3’. 
Overexpression of propeptide mutants and Western blot assays 
The MBP-McbA,-,, fusion proteins were expressed in BL21(DE3) 
cells cultures in LB media containing kanamycin (50 ug per ml). Cul- 
tures were induced with 1 mM IPTG in mid-log phase and harvested 
3 h later. Resuspended cells were lysed twice in a French press and 
purified using a single step affinity chromatography on an amylose 
column as described elsewhere [301. Purified MBP-McbA,-,, fusion 
proteins were assayed as substrates for CBP-tagged MccBl7 syn- 
thetase (CBP-McbBCD) using an in vitro Western blot assay 
described earlier t301. 
Accession numbers 
The NMR restraints and coordinates for the microcin leader peptide 
(accession numbers: r2mlpmr and 2mlp) have been deposited with the 
Protein Data Bank, Brookhaven National Laboratory, Upton, New York, 
11923, USA, from whom copies can be obtained. 
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Supplementary material 
Supplementary material published with this paper on the internet 
includes: two figures of NMR data and two tables of proton NMR reso- 
nance assignments for the microcin 817 leader peptide (McbA,-,,- 
CON&) in 40% TFE and in purely aqueous solution. 
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